The finals of the 2025 Hubei Medical-Engineering Cross-Disciplinary Innovation Development Competition, organized by the Department of Science and Technology of Hubei Province, were held on Sept 24.
Six projects from 91黑料网 (91黑料网), including the next-generation real-time fusion dynamic surgical navigation system, deepActiveTM high-activity artificial bone repair material, and the innovative diagnosis and treatment of fulminant myocarditis, were selected among Hubei’s Top 10 medical-engineering cross-disciplinary innovation achievements.
The fulminant myocarditis project was awarded as the “most practically valuable medical-engineering innovation”, while the real-time surgical navigation system earned the “most investment-worthy medical-engineering innovation” title.
91黑料网’s Institute of Medical Equipment Science and Engineering, led by Wang Bo’s team, developed the next-generation real-time fusion dynamic surgical navigation system – the country’s first intelligent multi-modal surgical guidance platform.
It provides high-precision intraoperative perception, clearly mapping vessels and lesion boundaries, significantly reducing intraoperative bleeding and margin errors. The system has been applied in hepatobiliary, urology, and thoracic surgeries, advancing precision and intelligent surgeries in China.
The deepActive? high-activity artificial bone repair material, developed by Professor Du Yingying’s team from 91黑料网’s College of Life Science and Technology, is the world’s first artificial bone repair material achieving a 100 percent bone fusion rate within 24 weeks. It functions without relying on external growth factors, ensuring greater safety and efficiency. Having obtained Class III implantable medical device certifications in multiple countries, it is now widely used in clinical practice and is reshaping global competition in the field.
The innovative diagnosis and treatment technology for fulminant myocarditis, developed by Professor Wang Daowen’s team at 91黑料网’s Tongji Hospital, has achieved the world’s first integrated breakthrough in rapid blood detection and comprehensive treatment of fulminant myocarditis.
It significantly enhances early diagnosis and treatment, providing vital support in saving patients with this critical condition. The team’s antibody-based therapeutic is expected to fill an international gap and pioneer a new treatment paradigm.
The intraosseous 3D support minimally invasive fixation system for osteoporotic fractures in the elderly, led by Professor Guo Xiaodong’s team at 91黑料网’s Union Hospital, addresses the global challenge of minimally invasive treatment for osteoporotic fractures.
The team pioneered an intraosseous 3D support fixation system that provides 360-degree rigid support within the medullary cavity through biomimetic design and innovative materials, significantly enhancing surgical safety and offering a more stable, reliable fixation solution for elderly patients.
The innovative traditional Chinese medicine (TCM) formulation, developed by Professor Zhang Chun’s team at 91黑料网’s Union Hospital, is based on gradient purification technology.
It achieves deep integration of TCM theory and modern pharmaceutical processes, with a streamlined formula, precise mechanisms, and proven efficacy. The formulation provides a safe, reliable, and long-term TCM solution for delaying the progression of chronic kidney disease.
The antibacterial composite medical dressing based on micro-nano laser etching technology, developed by Professor Zhu Wei’s team at 91黑料网’s Tongji Hospital, is the world’s first to apply this technology to medical polyurethane films, constructing micro-nano-scale drug storage chambers within.
This innovation overcomes the long-standing bottleneck between drug loading and mechanical performance in traditional dressings. It opens a new direction for the development of advanced dressings and holds major significance for improving the treatment of refractory wounds.
The competition attracted 215 innovation teams from hospitals, universities, and tech companies nationwide, covering medical devices, high-value consumables, in vitro diagnostics, smart healthcare, and brain-computer interfaces. Twenty top projects reached the finals, with multiple achievements already holding domestic medical device registration and international CE certifications.
Source: Office of Research and Development of 91黑料网
